| Literature DB >> 28699090 |
M D J Wolvers1,2, J B J Bussmann3, F Z Bruggeman-Everts4,5, S T Boerema6,4, R van de Schoot7,8, M M R Vollenbroek-Hutten6,4.
Abstract
PURPOSE: Increasing physical activity level is a generally effective intervention goal for patients who suffer from chronic cancer-related fatigue (CCRF). However, patients are unlikely to benefit equally from these interventions, as their behavioral starting points might vary substantially. Therefore, we explored patterns of physical behavior of participants who suffer from CCRF.Entities:
Keywords: Accelerometry; Cancer; Fatigue; Latent profiles analysis; Oncology; Physical behavior
Mesh:
Year: 2018 PMID: 28699090 PMCID: PMC5803288 DOI: 10.1007/s12529-017-9670-3
Source DB: PubMed Journal: Int J Behav Med ISSN: 1070-5503
Model results of the Ak series
|
| BIC | Entropy | LMR | BLRT | Profile proportions ( |
|---|---|---|---|---|---|
| 1 | 3435.299 | Not applicable | Not applicable | Not applicable | 172 |
| 2 | 3269.204 | 0.804 | 261.23 (.02) | <.001 | 72; 100 |
| 3 | 3218.251 | 0.848 | 147.25 (.23) | <.001 | 28; 71; 73 |
| 4a | Not available | 0.869 | Not performed | Not performed | 7; 49; 55; 61 |
| 5a | Not available | 0.901 | Not performed | Not performed | 4; 19; 40; 46; 63 |
K number of imposed profiles, BIC Bayesian information criterion, LMR Lo-Mendel-Rubin likelihood ratio test, BLRT bootstrapped likelihood ratio test
aNo stable models were estimated; the models with best log likelihoods after 200,000 random starts are reported
Fig. 1Standardized profile means (z-scores) of models A2 (left) and A3 (right). SB, dSB1, and dSB2 have switched signs, thus are defined “higher is better.” PAL physical activity level, MVPA moderate-to-vigorous intensity physical activity time, pMVPA prolonged bouts of MVPA, SB sedentary behavior time, pSB prolonged bouts of SB, dPAL and dSB (day part difference: 1 morning to afternoon, 2 afternoon to evening)
Model results of the A3 model
| Total samplec | Sedentary | Average | Active | |||||
|---|---|---|---|---|---|---|---|---|
|
| 71 (41%) | 73 (42%) | 28 (16%) | |||||
| Profile posterior probabilitiesb, mean (lowest) | 0.936 | 0.926 (.50) | 0.944 (.59) | 0.943 (.66) | ||||
| Profile posterior probabilities <0.8, | 20 (12%) | 11 (15%) | 7 (10%) | 2 (7%) | ||||
| mean | stdev | mean | stdev | mean | stdev | mean | stdev | |
| Physical activity level (cpm) ( | 790.3 | 217.0 | 609.7 | 71.0 | 834.1 | 43.6 | 1081.5 | 103.7 |
| MVPA (%) ( | 6.22 | 3.47 | 0.10 | 0.62 | 13.06 | 1.38 | 27.94 | 2.43 |
| Prolonged bouts of MVPA (min) ( | 10.64 a | 12.62 | 3.14 | 5.36 | 8.87 | 8.77 | 24.82 | 28.35 |
| Sedentary behavior time (%) ( | 78.36 | 7.21 | 84.84 | 2.09 | 76.02 | 2.39 | 69.85 | 4.18 |
| Prolonged bouts of SB (min) ( | 325.6 | 110.6 | 391.3 | 88.7 | 295.8 | 84.7 | 254.5 | 56.8 |
| dPAL1 (%-pt) ( | −17.47 | 35.07 | −28.83 | 41.70 | −3.72 | 17.7 | −27.15 | 30.5 |
| dPAL2 (%-pt) ( | −28.80 | 22.49 | −28.21 | 26.36 | 30.30 | 20.0 | −26.32 | 21.60 |
| dSB1 (%-pt) ( | 2.1 | 8.4 | 2.8 | 5.0 | 0.1 | 9.4 | 5.7 | 10.1 |
| dSB2 (%-pt) ( | 10.2 | 7.1 | 7.5 | 4.38 | 11.8 | 6.7 | 12.3 | 8.3 |
stdev standard deviation, MVPA moderate-to-vigorous intensity physical activity time, dPAL and dSB day part difference (1: morning to afternoon, 2: afternoon to evening)
aSkewness = 2.13; kurtosis = 6.66; median = 6.57. 15% of the total sample (n = 25) accrued >21 min of pMVPA per day, thus potentially accrues 150 min of pMVPA per week.
bThe profile mean (of those participants who were actually assigned to this specific profile) of the posterior probabilities for each profile. Between brackets is the lowest posterior probability with which a participant was assigned to that profile
c Supplementary Materials (T4) shows the bivariate covariances matrix and modeled covariances on the overall level of models A1 and A3
Predictive value of participant characteristics of the three-profile model
| Total sample | Eliminated in step | Average compared to sedentarya | Active compared to sedentarya | Active compared to averagea | |
|---|---|---|---|---|---|
| Age (years) | 55.8 (10.2) |
| −.047 (.105) | −0.024 (.372) | |
| Sex (male) | 28% | 2 (.698) | |||
| Education (≥ college degree) | 52.9% | 3 (.581) | |||
| Work status (> 8 h/week) | 53.8% | 6 (.423) | |||
| Body mass index (kg/m2) ( | 26.4 (5.1) | 9 (.061) | |||
| Weeks since last treatmentb | 206 (236) | 7 (.248) | |||
| Comorbid conditions (≥ 2) | 14.0% | 4 (.465) | |||
| Limitations by comorbid condition (≥ 3/4) | 37.8% |
| 1.48 (.011) | 0.015 (.977) | |
| Limitations by pain (≥ 4/7) | 32.8% | −0.923 (.046) |
| 1.035 (.136) | |
| Treatment: chemo | 69.6% | 8 (.27) | |||
| Treatment: radiotherapy | 59.7% | 1 (.717) | |||
| Treatment: stem cell transplant | 6.4% | 0c | |||
| Fatigue (8–56) | 42.0 (8.0) | 11 (.010) | |||
| Distress (0–42) | 14.3 (6.8) | 5 (.474) | |||
| Work ability (0–10) | 3.2 (1.7) | 10 (.035) |
aValues are reported as logodds (p value). Logodds > 0 indicate that the risk of the outcome falling in the comparison profile relative to the risk of the outcome falling in the referent profile increases as the variable increases. Univariate results are presented in the Supplementary Materials (T5)
bMedian: 126 weeks
cIn the active profile, only one participant had experienced a stem cell transplant; therefore, this factor was excluded from the analyses